Effects of glucagon-like peptide-1 receptor agonists on gastric mucosal visibility and retained gastric contents during EGD
Malcolm Chapman, Dalton A. Norwood, Christopher Price, Basma Abdulhadi, Kondal R. Kyanam Kabir Baig, Ali M. Ahmed, Shajan Peter, Justin S. Routman, Sergio A. Sánchez‐Luna, Elizabeth W. Duggan, Ramzi Mulki
Topics & Concepts
EsophagogastroduodenoscopyMedicineInternal medicineGlucagon-like peptide-1GastroenterologyEndocrinologyEndoscopyDiabetes mellitusType 2 diabetesEnhanced Recovery After SurgeryBariatric Surgery and OutcomesGastrointestinal motility and disorders